Nanoparticle scavengers for medical countermeasures against mycotoxin

用于霉菌毒素医疗对策的纳米颗粒清除剂

基本信息

  • 批准号:
    8524115
  • 负责人:
  • 金额:
    $ 23.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mycotoxin is naturally occurring and is a toxic small molecule produced by fungi. These fungal toxins are representative of a large number of lipophilic agents that pose significant acute and chronic dangers to military combatants as potential warfare agents. There are many examples of mycotoxins, some more acutely potent than others. Mycotoxin is classified as hepatotoxins, nephrotoxins, neurotoxins, immunotoxins, and carcinogens. Mycotoxin could also be a threat to the public health due to food, water or air contamination. Currently, there are no treatments for mycotoxin exposure in either the acute or chronic setting, and the lack of an effective therapeutic could be catastrophic. In order to protec the safety and health of military personnel and civilians, there is a need to develop a therapeutic and prophylactic drug, which can effectively reduce concentrations below its toxic level and minimize the incidence of clinical toxicity. Luna proposes to develop nanoparticle scavengers that can efficiently sequester the lipophilic mycotoxins in vivo and facilitate their clearance. Ths nanotechnology-based approach offers the potential to treat people under suspicion of actual or potential mycotoxin poisoning. Phase I efforts will focus on demonstrating proof-of-concept in vivo efficacy at attenuating mycotoxin-induced acute toxicities, and demonstrating the safe use of Luna's nanoparticles in one rodent species. Phase II efforts will focus on IND-enabling preclinical studies. Success of the program will provide a valuable medical countermeasure tool against mycotoxins, and it may also find clinical applications for other lipophilic toxins or for overdosed drug toxicities. The nanoparticle antidotes could be important for the Strategic National Stockpile in preparing for an emergency involving bioterrorism. Thus, this proposed technology is of great interest to the public health, and also enhances the nation's preparedness against potential mycotoxin attacks.
描述(由申请人提供):真菌毒素是自然产生的,是一种由真菌产生的有毒小分子。这些真菌毒素是大量亲脂剂的代表,它们作为潜在的战争剂对军事战斗人员构成严重的急性和慢性危险。真菌毒素的例子很多,有些比其他的更强烈。真菌毒素分为肝毒素、肾毒素、神经毒素、免疫毒素和致癌物。由于食物、水或空气污染,霉菌毒素也可能对公众健康构成威胁。目前,无论是急性还是慢性真菌毒素暴露都没有治疗方法,缺乏有效的治疗方法可能是灾难性的。为了保护军事人员和平民的安全和健康,有必要开发一种治疗方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhiguo Zhou其他文献

Zhiguo Zhou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhiguo Zhou', 18)}}的其他基金

Fullerene-based Radioprotectors for Use during Brain Radiotherapy, Period of Performance 09/15/2014 - 05/15/2015
用于脑部放射治疗期间使用的富勒烯放射防护剂,执行期间 09/15/2014 - 05/15/2015
  • 批准号:
    8948732
  • 财政年份:
    2014
  • 资助金额:
    $ 23.49万
  • 项目类别:
Developing New Assessment Tools for Carbon Nanomaterial-Based Contaminants
开发基于碳纳米材料的污染物的新评估工具
  • 批准号:
    8714259
  • 财政年份:
    2014
  • 资助金额:
    $ 23.49万
  • 项目类别:
Nanoparticle scavengers for in vivo sequestration of overdosed drug molecules
用于体内隔离过量药物分子的纳米颗粒清除剂
  • 批准号:
    8524099
  • 财政年份:
    2013
  • 资助金额:
    $ 23.49万
  • 项目类别:
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis
用于癌症诊断的改进金属富勒烯 MRI 造影剂
  • 批准号:
    8686795
  • 财政年份:
    2013
  • 资助金额:
    $ 23.49万
  • 项目类别:
Enhanced bioscavenger for medical countermeasures against organophosphorus agents
用于针对有机磷制剂的医疗对策的增强型生物清除剂
  • 批准号:
    8524618
  • 财政年份:
    2013
  • 资助金额:
    $ 23.49万
  • 项目类别:
Improved Metallofullerene MRI Contrast Agent for Cancer Diagnosis
用于癌症诊断的改进金属富勒烯 MRI 造影剂
  • 批准号:
    8507969
  • 财政年份:
    2013
  • 资助金额:
    $ 23.49万
  • 项目类别:
TAS::75 0849::TAS MULTIFUNCTIONAL NANODEVICE FOR TARGETED CANCER MR IMAGING AND
TAS::75 0849::TAS 用于靶向癌症 MR 成像的多功能纳米设备
  • 批准号:
    8165882
  • 财政年份:
    2010
  • 资助金额:
    $ 23.49万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 23.49万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了